ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

MLTX MoonLake Immunotherapeutics

45.02
0.00 (0.00%)
Pre Market
Last Updated: 09:09:54
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -30.88M-14.77M-16.7M-12.93M-13.19M-12.98M-15.03M-19.82M
Pre Tax Income -30.58M-14.73M-16.46M-12.21M-12.34M-11.59M-7.84M-13.91M
Net Income -30.59M431k-31.64M-12.22M-12.35M-11.62M-7.89M-13.98M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -30.57M-14.73M-16.46M-12.21M-12.34M-11.59M-7.84M-13.91M
EBITDA -30.88M-14.77M-16.69M-12.93M-13.18M-12.97M-15.03M-19.8M
Year End 31 December 2023 2020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0000
Operating Income -106k-4.57M-65.06M-54.12M
Pre Tax Income -91k-4.54M-64.47M-43.99M
Net Income -91k-4.54M-64.51M-44.08M
Preferred Dividends 0000
Basic Earnings Per Share (EPS) -0.003-0.153-0.463-0.277
EBIT -106k-4.57M-64.47M-43.99M
EBITDA -106k-4.57M-65.05M-54.11M